We have established a three-tiered translational technology initiative for facilitating pacing the next generation Epilepsy Treatment Centers.
1) The primary diagnostic tier: evolve innovative diagnostic functional neuroimaging technologies that facilitate visualizing the foot-prints of 'epileptogenic' brain circuits.
2) The dominant treatment tier: develop game-changing nano-control interfaces for stabilizing medication-resistant fragile brain networks.
3) Our clinical presence tier: develop and deploy transformational rural epilepsy care utilizing novel mobile health biosensing strategies coordinated by an innovative community-based population health management hub.
Together our aims strive to maximize 'effective connectivity from synapse to community'.